Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions

Radiotherapy and Oncology

Volumn 64, Issue 1, 2002, Pages 1-12

  Fiorino, Claudio ^a   Cozzarini, Cesare ^a   Vavassori, Vittorio ^b   Sanguineti, Giuseppe ^c   Bianchi, Carla ^b   Mauro Cattaneo, Giovanni ^a   Foppiano, Franca ^c   Magli, Alessandro ^b   Piazzolla, Anna ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Conformal radiotherapy; Dose volume histograms; Normal tissue complications; Prostate; Rectum bleeding

Indexed keywords

ADULT; AGE; AGED; AIR; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; FECES; HIGH RISK POPULATION; HISTOGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; RECTUM HEMORRHAGE; RISK; SCORING SYSTEM; SIGMOID; STATISTICAL ANALYSIS; CLINICAL TRIAL; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; RADIATION EXPOSURE; RADIATION INJURY; RECTUM; RETROSPECTIVE STUDY; RISK FACTOR;

ACTUARIAL ANALYSIS; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RECTUM; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036661467     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00147-0     Document Type: Article

References (49)

1. Bedford J.L., Khoo V.S., Oldham M., Adams E.J., Dearneley D.P., Webb S. A comparison of coplanar 4-fields techniques for conformal radiotherapy of the prostate. Radiother Oncol. 52:1999;225-235.
2. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
3. Cho K.H., Lee C.K.K., Levitt S.H. Proctitis after conventional external radiation therapy for prostate cancer: importance of minimizing posterior rectal dose. Radiology. 198:1995;699-703.
4. Cozzarini C., Fiorino C., Mandelli D., et al. 3D conformal radiotherapy significantly reduces toxicity of post-prostatectomy adjuvant or salvage irradiation. Int J Radiat Oncol Biol Phys. 48:2000;248. (Abstract).
5. Dale E., Olsen D.R., Fossa S.D. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys. 43:1999;385-391.
6. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet. 353:1999;267-272.
7. Declich F., Fumasoni K., Mangili P., Cattaneo G.M., Iori M. Dosimetric evaluation of a commercial 3-D treatment planning system using Reoport 55 by AAPM Task group 23. Radiother Oncol. 52:1999;69-77.
8. Fenwick J.D. Impact of dose-distribution uncertainties on rectal ntcp modelling II: uncertainty implications. Med Phys. 28:2001;570-581.
9. Fenwick J.D., Nahum A.E. Impact of dose-distribution uncertainties on rectal ntcp modelling I: uncertainty estimates. Med Phys. 28:2001;560-569.
10. Fenwick J.D., Khoo V.S., Nahum A.E., Sanchez-Nieto B., Dearnaley D. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 49:2001;473-480.
11. Fiorino C., Reni M., Cattaneo G.M., Bolognesi A., Calandrino R. Comparing 3-, 4- and 6-fields techniques for conformal irradiation of prostate and seminal vesicles using dose-volume histograms. Radiother Oncol. 44:1997;251-257.
12. Fiorino C., Reni M., Bolognesi A., et al. Set-up error in supine-positioned patients immobilized with two different modalities during conformal radiotherapy of prostate cancer. Radiother Oncol. 49:1998;133-141.
13. Fiorino C., Reni M., Bolognesi A., et al. Intra and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol. 47:1998;285-292.
14. Fiorino C., Vavassori V., Sanguineti G., et al. Rectum contouring variability in patients treated for prostate cancer: impact on rectum DVHs and NTCP. Radiother Oncol. 2002;. (in press).
15. Forman J.D., Zinreich E., Lee D.J., Wharam M., Baumgardner R.A., Order S.E. Improving the therapeutic ratio of external beam irradiation for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 11:1985;2073-2080.
16. Hanks G.E. Conformal radiation in prostate cancer: reduced morbidity with hope of increased local control. Int J Radiat Oncol Biol Phys. 25:1993;377-378.
17. Hanks G.E., Marta K.L., Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys. 15:1988;1299-1305.
18. Hartford A.C., Niemierko A., Adams J.A., et al. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys. 36:1998;721-730.
19. Hoogeman M.S., de Bois J.A., Muller-Timmermans P., et al. The use of 2D-dose maps to determine the effect of organ motion on the use to the rectal wall. Radiother Oncol. 61:(Suppl 1):2001;S37. (Abstract).
20. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 49:2001;685-698.
21. Killoran J.H., Kooy H.K., Gladstone D.J., et al. A numerical simulation of organ motion and daily setup uncertainties: implications for radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;213-221.
22. Lebesque J.V., Allison D., Bruce A.M., et al. Variation in volumes, dose-volume histograms and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys. 33:1995;1109-1119.
23. Lee R.W., Hanks G.E., Hanlon A.L., Schultheiss T.E., Hunt M.A. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys. 35:1996;251-257.
24. Lu Y., Song P.Y., Li S.D., et al. A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys. 33:1995;1121-1125.
25. MacKay R.I., Hendry J.H., Moore C.J., et al. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br J Radiol. 70:1997;517-526.
26. Mageras G.S., Kutcher G.J., Leibel S.A., et al. A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. Int J Radiat Oncol Biol Phys. 35:1996;333-342.
27. Meijer G.J., van der Brink M., Hoogeman M.S., Meinders J., Lebesque J.V. Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy. Int J Radiat Oncol Biol Phys. 45:1999;1073-1080.
28. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. 46:(2):2000;391-402.
29. Milano F., Masi L., Casamassima F., Hlavata H. Application of the AAPM TG23 test to a commercial treatment planning system. Radiother Oncol. 56:2000;S210. (Abstract).
30. Padhani A.R., Khoo V.S., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys. 44:1999;525-533.
31. Perez C.A., Michalski J.M., Purdy J.A., Wasserman T.H., Williams K., Lockett M.A. Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 47:2000;629-637.
32. Pollack A., Zagars G.K., Starkschall G., et al. Conventional versus conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys. 34:1996;555-564.
33. Ragazzi G., Mangili P., Fiorino C., et al. Variations of tumor control and rectum complication probabilities due to random set-up errors during conformal radiotherapy of prostate cancer. Radiother Oncol. 44:1997;258-261.
34. Sanchez Nieto B., Fenwick J.F., Nahum A.E., Dearneley D.P. Biological dose-surface maps: evaluation of 3D dose data for tubular organs. Radiother Oncol. 61:(Suppl 1):2001;S52. (Abstract).
35. Sandler H.M., Perez-Tamayo C., Ten Haken R.K., Lichter A.S. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol. 23:1992;53-54.
36. Sanguineti G, Franzone P, Marcenaro M, Paoli G, Orsatti M, Vitale V. Androgen deprivation impacts late rectal toxicity after conformal radiotherapy. Abstr # 1328. page 338a. Proceedings of 36 Annual ASCO Meeting, New Orleans, LA, May 20-23, 2000
37. Schulteiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;3-11.
38. Skwarchuk M.W., Jackson A., Zelefsky M. Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: what is the best way to define the rectal length and volume? Int J Radiat Oncol Biol Phys. (Suppl 1):1999;261. (abstract).
39. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose response. Int J Radiat Oncol Biol Phys. 47:2000;103-113.
40. Smit W.G.J.M., Helle P.A., Van Putten W.L.J., et al. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys. 18:1990;23-29.
41. Stroom J.C., De Boer H.C.J., Huizenga H., et al. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys. 43:1999;905-919.
42. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 48:2000;635-642.
43. Van Herk M., Remjier P., Rasch C., Lebesque J.V. Dose-population histograms for incorporating geometric treatment deviations. Int J Radiat Oncol Biol Phys. 42:(Suppl 1):1998;102. (Abstract).
44. Vijayakumar S, Awan A, Karrison T, et al. Acute toxicity during external-beam radiotherapy for localized prostate cancer: Comparison of different techniques. Int J Radiat Oncol Biol Phys 1993;25:359-71.
45. Wachter S., Gerstner N., Goldner G., Potzi R., Wambersie A., Potter R. Endoscopic scoring of late rectal mucosa damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol. 54:2000;11-19.
46. Wachter S., Gerstner N., Goldner G., Potzi R., Wambersie A., Potter R. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol. 59:2001;65-70.
47. Yan D., Jaffray D.A., Wong J.W. A model to accumulate fractionated dose in a deforming organ. Int J Radiat Oncol Biol Phys. 44:1999;665-675.
48. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
49. Zelefsky M.J., Cowen D.M., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 85:1999;2460-2468.